KRYS - Krystal Biotech, Inc.
IEX Last Trade
159.265
-1.780 -1.118%
Share volume: 4,354
Last Updated: Fri 27 Dec 2024 05:30:08 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.39%
PREVIOUS CLOSE
CHG
CHG%
$161.04
-1.78
-1.11%
Summary score
15%
Profitability
15%
Dept financing
2%
Liquidity
50%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
18.75%
Return on assets
-7.79%
Return on sales
0%
Return on invested capital
350.41%
Total debt ratio
24.68%
Debt ratio change over timeo
-0.98%
Current Ratio
46.55%
Quick Ratio
0%
Cash Position Ratio
44.25%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-2.51%
Return on assets
-2.68%
Return on sales
0%
Return on invested capital
-48.7%
Total debt ratio
2.96%
Debt ratio change over timeo
-1.05%
Current Ratio
52.15%
Quick Ratio
0%
Cash Position Ratio
50.25%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-2.21%
Return on assets
-2.19%
Return on sales
0%
Return on invested capital
-49.6%
Total debt ratio
2.66%
Debt ratio change over time
-1.06%
Current Ratio
51.2%
Quick Ratio
0%
Cash Position Ratio
50.02%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-101.31%
Return on assets
-101.11%
Return on sales
0%
Return on invested capital
77.9%
Total debt ratio
-97.62%
Debt ratio change over time
-0.98%
Current Ratio
-9.65%
Quick Ratio
0%
Cash Position Ratio
-8.89%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KRYS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 18.75% | -3.05% | 11.55% | 6.27% |
| Return on assets | -7.79% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 350.41% | 5.09% | 7.99% | 13.19% |
| Profitability | 50% | 36% | 58% | 54% |
| Total debt ratio | 24.68% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.98% | 6.09% | 6.03% | 1.53% |
| Dept financing | 6% | 50% | 43% | 14% |
| Current Ratio | 52.15% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 50.25% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 11% | 27% | 26% |
| Short-term ratios | KRYS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -2.51% | -25.62% | 17.94% | 7.14% |
| Return on assets | -2.68% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -48.7% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 2.96% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.05% | -23.44% | 9.66% | 0.6% |
| Dept financing | 1% | 25% | 45% | 8% |
| Current Ratio | 52.15% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 50.25% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 19% | 16% | 27% |